Crabel Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Crabel Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-120,337	Closed	-$4M	–	108
2022 Q4	$4M	Hold	120,337	–	–	1.45%	29
2022 Q3	$3.79M	Buy	+120,337	New	+$3.9M	2.22%	24

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crabel Capital Management's VIVO Position: Q1 2023 in Review

Crabel Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 120,337 shares — an estimated $4M sold.

Crabel Capital Management first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $4M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Crabel Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Crabel Capital Management sold 120,337 Meridian Bioscience Inc shares in Q1 2023, an estimated $4M.
Crabel Capital Management first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Crabel Capital Management's Meridian Bioscience Inc position peaked at $4M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Crabel Capital Management's 13F filing for Q1 2023, filed 15 May 2023.